Immunosurveillance, Immunoscore & Personalized Cancer Immunotherapy – an interview with Jérôme Galon
Dr Jérôme Galon is a leading Immunologist and Research Director at INSERM in Paris.
At the recent European Cancer Congress in Vienna he gave an engaging presentation in the scientific symposium on Cellular Immunotherapy of Cancer.
Afterwards, Dr Galon (pictured right) kindly spoke to BSB about:
- What is immunosurveillance?
- How the type, location and density of immune cells present within tumors predicts clinical outcome.
- The potential of the Immunoscore assay to classify cancers based on their immune profile
- What the future may hold in terms of personalized cancer immunotherapy.
One only has look at the impressive list of companies for which Dr Galon is a consultant or scientific adviser to see how valued his work in the cancer immunotherapy field is; it was a privilege to talk with him. The excerpts of the in-depth interview he kindly gave make for a good weekend read!
Grab a coffee & bagel and enjoy!
To learn more insights on this intriguing topic, subscribers can log-in or you can purchase access to BSB Premium Content.
This content is restricted to subscribers
